Comments
Aurobindo Pharma Ltd has received tentative approval from the US Food & Drug Administration (USFDA) to manufacture and market its anti-AIDS combination drug Efavirenz/ Emtricitabine and Tenofovir Disoproxil Fumarate Tablets.
The Hyderabad-based company was one of the first generics companies to have received this approval, according to a release.
The drug is the generic equivalent of Gilead Sciences Inc’s Atripla tablets and falls under the anti-retroviral (ARV) segment.
It is indicated in combination with other anti-retroviral agents for the treatment of HIV-1 infection in adults.
"This Abbreviated New Drug Application (ANDA) was reviewed under the expedited provisions of the President’s Emergency Plan for AIDS relief (PEPFAR)," the company said.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.